Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for...
THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed...
“I Dare the FDA not to Approve Our Drug.”
"Woe, Woe, Woe Wait a Minute. We Meant That Biogen Respects and Appreciates the FDA Review Process.” All Hail the FDA! Biogen...
True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.
This is a Welcome Step in the Right Direction.
ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Frontier Bio (FBIO) Bolstering it’s Warchest.
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Is True Nature (TNTY) $0.04, Nearing a Breakout?
After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
True Nature | Mitesco (TNTY), Perking Up.
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...
Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?
New technology could revolutionize market of 500 million diabetes patients (i24 News).
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
